Compare · head to head
Cytokinetics vs Xenon Pharmaceuticals
Xenon Pharmaceuticals ranks higher overall — 360 rank 28 vs 13.
Cytokinetics leads on Quality (51 vs 42) and Growth (47 vs 35). Xenon Pharmaceuticals leads on Safety (43 vs 31) and Sentiment (56 vs 40).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | Canada |
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Biotechnology |
| Size | Small | Small |
| ISIN | US23282W6057 | CA98420N1050 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 13 | 28 |
| Value | 36 | NR |
| Quality | 51 | 42 |
| Growth | 47 | 35 |
| Safety | 31 | 43 |
| Sentiment | 40 | 56 |
| Quality details | ||
| Profitability | NR | 35 |
| Cash Truth | 52 | NR |
Full analyses: Cytokinetics · Xenon Pharmaceuticals
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100